Very late stent thrombosis associated with stent malapposition and uncovered struts after contrast-enhanced CT in a patient receiving long-term steroid therapy due to Kounis syndrome: a case report

一例因 Kounis 综合征接受长期类固醇治疗的患者,在增强 CT 检查后发现支架贴壁不良和支架梁裸露,并伴有极晚期支架血栓形成:病例报告

阅读:2

Abstract

BACKGROUND: Kounis syndrome (KS) is an acute coronary syndrome triggered by allergic or hypersensitivity reactions and is classified into three variants: coronary vasospasm, plaque rupture, and stent thrombosis. Type III KS involving stent thrombosis is extremely rare. The mechanisms linking allergic triggers with very late stent thrombosis (VLST) remain insufficiently characterized. CASE SUMMARY: We present a rare case of Type III KS triggered by contrast media in a 74-year-old man with a history of everolimus-eluting stent implantation ∼1 year and 10 months prior to presentation and chronic corticosteroid therapy for membranous nephropathy. Shortly after a contrast-enhanced computed tomography scan, the patient developed an ST-elevated myocardial infarction. Optical frequency-domain imaging revealed a heavy thrombus burden, malapposed stent struts, and uncovered struts. The drug-induced lymphocyte stimulation test was positive for iopamidol, confirming contrast-induced KS. DISCUSSION: This case highlights the potential interplay between mechanical vulnerability (malapposition and uncovered struts) and allergic responses in the pathogenesis of VLST. Chronic corticosteroid therapy may have delayed vascular healing, contributing to persistent uncovered struts. The combination of stent-related factors and systemic hypersensitivity likely promoted thrombus formation. Physicians should consider KS in the differential diagnosis of stent thrombosis even if it occurs long after percutaneous coronary intervention or if the patient is receiving long-term corticosteroid therapy.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。